Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Francesco Panza, Davide Seripa, Madia Lozupone, Vincenzo Solfrizzi, Bruno P. Imbimbo, Maria Rosaria Barulli, Rosanna Tortelli, Rosa Capozzo, Paola Bisceglia, Andrea Dimitri, Roberta Stallone, Vittorio Dibello, Nicola Quaranta, Antonio Daniele, Antonello Bellomo, Antonio Greco & Giancarlo Logroscino. (2018) The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset. Expert Opinion on Biological Therapy 18:1, pages 25-35.
Read now
Read now
Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, Bruno P. Imbimbo, Madia Lozupone, Antonio Leo, Rodolfo Sardone, Gaetano Gagliardi, Lucia Lofano, Bianca C. Creanza, Paola Bisceglia, Antonio Daniele, Antonello Bellomo, Antonio Greco & Giancarlo Logroscino. (2016) Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients. Expert Opinion on Emerging Drugs 21:4, pages 377-391.
Read now
Read now
Articles from other publishers (35)
Fahad Saad Alhodieb, Mohammad Akhlaquer Rahman, Muhammad Abul Barkat, Abdulkareem A Alanezi, Harshita Abul Barkat, Hazrina Ab Hadi, Ranjit K Harwansh & Vineet Mittal. (2023) Nanomedicine-driven therapeutic interventions of autophagy and stem cells in the management of Alzheimer's disease. Nanomedicine 18:2, pages 145-168.
Crossref
Crossref
Dong-Hun Lee, Ji Young Lee, Dong-Yong Hong, Eun Chae Lee, Sang-Won Park, Yu Na Jo, Yu Jin Park, Jae Young Cho, Yoo Jin Cho, Su Hyun Chae, Man Ryul Lee & Jae Sang Oh. (2022) ROCK and PDE-5 Inhibitors for the Treatment of Dementia: Literature Review and Meta-Analysis. Biomedicines 10:6, pages 1348.
Crossref
Crossref
Valentina Oliveri & Graziella Vecchio. (2021) Bis(8‐hydroxyquinoline) Ligands: Exploring their Potential as Selective Copper‐Binding Agents for Alzheimer's Disease. European Journal of Inorganic Chemistry 2021:21, pages 1993-1999.
Crossref
Crossref
James D. Grayson, Matthew P. Baumgartner, Cleide Dos Santos Souza, Samuel J. Dawes, Imane Ghafir El Idrissi, Jennifer C. Louth, Sasha Stimpson, Emma Mead, Charlotte Dunbar, Joanna Wolak, Gary Sharman, David Evans, Anastasia Zhuravleva, Margarita Segovia Roldan, Nicola Antonio Colabufo, Ke Ning, Claire Garwood, James A. Thomas, Benjamin M. Partridge, Antonio de la Vega de Leon, Valerie J. Gillet, Amélia P. Rauter & Beining Chen. (2021)
Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo–PrP
C
binding and downstream pathways
. Chemical Science 12:10, pages 3768-3785.
Crossref
Crossref
Samuel King & Cenk Suphioglu. 2020. Neuroprotection - New Approaches and Prospects. Neuroprotection - New Approaches and Prospects.
Colman Moore, Ryan Wing, Timothy Pham & Jesse V. Jokerst. (2020) Multispectral Nanoparticle Tracking Analysis for the Real-Time and Label-Free Characterization of Amyloid-β Self-Assembly In Vitro. Analytical Chemistry 92:17, pages 11590-11599.
Crossref
Crossref
Stefan M. Ivanov, Mariyana Atanasova, Ivan Dimitrov & Irini A. Doytchinova. (2020) Cellular polyamines condense hyperphosphorylated Tau, triggering Alzheimer’s disease. Scientific Reports 10:1.
Crossref
Crossref
Mirna Swayden, Philippe Soubeyran & Juan Iovanna. (2020) Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma. Frontiers in Oncology 9.
Crossref
Crossref
Vadim Keyser & Louis Sarry. 2020. Uncertainty in Pharmacology. Uncertainty in Pharmacology
289
318
.
Elizabeth S. Smith, Joshua E. Porterfield & Rangaramanujam M. Kannan. (2019) Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders. Advanced Drug Delivery Reviews 148, pages 181-203.
Crossref
Crossref
David Blokh, Ilia Stambler, Emilia Lubart & Eliyahu H. Mizrahi. (2019) An Information Theory Approach for the Analysis of Individual and Combined Evaluation Parameters of Multiple Age-Related Diseases. Entropy 21:6, pages 572.
Crossref
Crossref
John F. Hodes, Carlee I. Oakley, James H. O'Keefe, Peilin Lu, James E. Galvin, Nabeel Saif, Sonia Bellara, Aneela Rahman, Yakir Kaufman, Hollie Hristov, Tarek K. Rajji, Anne Marie Fosnacht Morgan, Smita Patel, David A. Merrill, Scott Kaiser, Josefina Meléndez-Cabrero, Juan A. Melendez, Robert Krikorian & Richard S. Isaacson. (2019) Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice. Frontiers in Neurology 9.
Crossref
Crossref
Mehmet Murat Koseoglu, Andrés Norambuena, Elizabeth R. Sharlow, John S. Lazo & George S. Bloom. (2019) Aberrant Neuronal Cell Cycle Re-Entry: The Pathological Confluence of Alzheimer’s Disease and Brain Insulin Resistance, and Its Relation to Cancer. Journal of Alzheimer's Disease 67:1, pages 1-11.
Crossref
Crossref
Acharaporn Issuriya, Ekkasit Kumarnsit, Chayaporn Reakkamnuan, Nifareeda Samerphob, Pornchai Sathirapanya & Dania Cheaha. (2019) Dexamethasone induces alterations of slow wave oscillation, rapid eye movement sleep and high-voltage spindle in rats. Acta Neurobiologiae Experimentalis 79:3, pages 252-261.
Crossref
Crossref
Ilia Stambler. 2019. The Transhumanism Handbook. The Transhumanism Handbook
381
396
.
H. Robert Brashear, Nzeera Ketter, Jennifer Bogert, Jianing Di, Stephen P. Salloway & Reisa Sperling. (2018) Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies. Journal of Alzheimer's Disease 66:4, pages 1409-1424.
Crossref
Crossref
Dario Carradori, Claudia Balducci, Francesca Re, Davide Brambilla, Benjamin Le Droumaguet, Orfeu Flores, Alice Gaudin, Simona Mura, Gianluigi Forloni, Lara Ordoñez-Gutierrez, Francisco Wandosell, Massimo Masserini, Patrick Couvreur, Julien Nicolas & Karine Andrieux. (2018) Antibody-functionalized polymer nanoparticle leading to memory recovery in Alzheimer's disease-like transgenic mouse model. Nanomedicine: Nanotechnology, Biology and Medicine 14:2, pages 609-618.
Crossref
Crossref
Steffen E. Storck & Claus U. Pietrzik. (2017) Endothelial LRP1 – A Potential Target for the Treatment of Alzheimer’s Disease. Pharmaceutical Research 34:12, pages 2637-2651.
Crossref
Crossref
Doreen Osgood, Miles C. Miller, Arthur A. Messier, Liliana Gonzalez & Gerald D. Silverberg. (2017) Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier. Neurobiology of Aging 57, pages 178-185.
Crossref
Crossref
Marina Chemerovski‐Glikman, Moran Frenkel‐Pinter, Ragad Mdah, Amjaad Abu‐Mokh, Ehud Gazit & Daniel Segal. (2017) Inhibition of the Aggregation and Toxicity of the Minimal Amyloidogenic Fragment of Tau by Its Pro‐Substituted Analogues. Chemistry – A European Journal 23:40, pages 9618-9624.
Crossref
Crossref
R Derungs, G G Camici, R D Spescha, T Welt, C Tackenberg, C Späni, F Wirth, A Grimm, A Eckert, R M Nitsch & L Kulic. (2016) Genetic ablation of the p66Shc adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer’s disease. Molecular Psychiatry 22:4, pages 605-614.
Crossref
Crossref
Diane B. Miller & James P. O'Callaghan. (2017) New horizons for focused ultrasound (FUS) – therapeutic applications in neurodegenerative diseases. Metabolism 69, pages S3-S7.
Crossref
Crossref
Nitin Charbe, Paul A McCarron & Murtaza M Tambuwala. (2017) Three-dimensional bio-printing: A new frontier in oncology research. World Journal of Clinical Oncology 8:1, pages 21.
Crossref
Crossref
Ilia Stambler. (2017) Recognizing Degenerative Aging as a Treatable Medical Condition: Methodology and Policy. Aging and disease 8:5, pages 583.
Crossref
Crossref
Youmei Wang, Tao Yan, Honghui Lu, Weiming Yin, Bin Lin, Weibin Fan, Xiaoli Zhang & Pedro Fernandez-Funez. (2017) Lessons from Anti-Amyloid-β Immunotherapies in Alzheimer Disease: Aiming at a Moving Target. Neurodegenerative Diseases 17:6, pages 242-250.
Crossref
Crossref
Moran Frenkel-Pinter, Sharon Tal, Roni Scherzer-Attali, Malak Abu-Hussien, Idan Alyagor, Tal Eisenbaum, Ehud Gazit & Daniel Segal. (2017) Cl-NQTrp Alleviates Tauopathy Symptoms in a Model Organism through the Inhibition of Tau Aggregation-Engendered Toxicity. Neurodegenerative Diseases 17:2-3, pages 73-82.
Crossref
Crossref
Brinda Tammara, Sangeeta Raje, William McKeand & Joan M. Korth-Bradley. 2017. Translating Molecules into Medicines. Translating Molecules into Medicines
341
372
.
Todd E. Golde. (2016) Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies. Journal of Neurochemistry 139, pages 224-236.
Crossref
Crossref
Carlos J.V. Simões, Zaida L. Almeida, Dora Costa, Catarina S.H. Jesus, Ana L. Cardoso, Maria R. Almeida, Maria J. Saraiva, Teresa M.V. D. Pinho e Melo & Rui M.M. Brito. (2016) A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition. European Journal of Medicinal Chemistry 121, pages 823-840.
Crossref
Crossref
Alessandro Sinopoli, Alessandro Giuffrida, Marianna Flora Tomasello, Maria Laura Giuffrida, Marilisa Leone, Francesco Attanasio, Filippo Caraci, Paolo De Bona, Irina Naletova, Michele Saviano, Agata Copani, Giuseppe Pappalardo & Enrico Rizzarelli. (2016) Ac-LPFFD-Th: A Trehalose-Conjugated Peptidomimetic as a Strong Suppressor of Amyloid-β Oligomer Formation and Cytotoxicity. ChemBioChem 17:16, pages 1541-1549.
Crossref
Crossref
Kenneth Hensley & Petri Kursula. (2016) Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer’s Disease: Comparison and Contrast with Microtubule-Associated Protein Tau. Journal of Alzheimer's Disease 53:1, pages 1-14.
Crossref
Crossref
H. D. Soares, M. Gasior, J. H. Toyn, J.-S. Wang, Q. Hong, F. Berisha, M. T. Furlong, J. Raybon, K. A. Lentz, F. Sweeney, N. Zheng, B. Akinsanya, R. M. Berman, L. A. Thompson, R. E. Olson, J. Morrison, D. M. Drexler, J. E. Macor, C. F. Albright, M. K. Ahlijanian & M. AbuTarif. (2016) The -Secretase Modulator, BMS-932481, Modulates A Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers. Journal of Pharmacology and Experimental Therapeutics 358:1, pages 138-150.
Crossref
Crossref
James A. Hendrix, Randall J. Bateman, H. Robert Brashear, Cynthia Duggan, Maria C. Carrillo, Lisa J. Bain, Ronald DeMattos, Russell G. Katz, Susanne Ostrowitzki, Eric Siemers, Reisa Sperling & Ottavio V. Vitolo. (2016) Challenges, solutions, and recommendations for Alzheimer's disease combination therapy. Alzheimer's & Dementia 12:5, pages 623-630.
Crossref
Crossref
Sandeep Kumar, A. Mary Thangakani, R. Nagarajan, Satish K. Singh, D. Velmurugan & M. Michael Gromiha. (2016) Autoimmune Responses to Soluble Aggregates of Amyloidogenic Proteins Involved in Neurodegenerative Diseases: Overlapping Aggregation Prone and Autoimmunogenic regions. Scientific Reports 6:1.
Crossref
Crossref
Ioannis Tarnanas, Anthoula Tsolaki, Mark Wiederhold, Brenda Wiederhold & Magda Tsolaki. (2015) Five‐year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 1:4, pages 521-532.
Crossref
Crossref